• Home
  • About Biowin
  • Contact us
BioWin
Win Health | The health blog of Wallonia
468 X 60
  • Biopharmacy
  • Cell therapy
  • Radiopharmacy
  • Biotech products
  • Diagnostics
  • Medical devices
  • Imaging
  • Support
    • Investment
    • Partnering

Archive for 'Tag Archives: 'vaccines''

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

Belgian-based ImCyse, a spin-off originally from the Catholic University of Leuven (KUL), but now established at both KUL and University of Liège (ULg), was founded in July 2010 by Prof. Jean-Marie Saint-Remy to valorize discoveries made [...]

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Now hiring! Quality Assistance (QA), a contract research organization (CRO) dedicated to 3rd generation medicines, has announced a €4.5 million investment over the next 18 months and a commitment to creating 15 new jobs by the [...]

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

In March, GlaxoSmithKline(GSK) and the Texas A&M University System (TAMUS) announced the U.S. Department of Health and Human Services (DHHS) had approved the establishment of a $91 million (€70.3 million) influenza-vaccine manufacturing facility as the pillar [...]

BioWin Day 2016

  • Popular
  • Recent
  • Comments
  • Tags
UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes


June 21, 2013
Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners


January 16, 2014
Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)


January 17, 2014
Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round


January 22, 2014
ZenTech Biotechnology, an example of international development!

ZenTech Biotechnology, an example of international development!


February 06, 2014
Imaging beta-cells for better diabetes treatment

Imaging beta-cells for better diabetes treatment


March 22, 2018
Walloon radioisotope in the fight against cancer

Walloon radioisotope in the fight against cancer


October 23, 2017
Personalised arthritis medicine saves lots of money

Personalised arthritis medicine saves lots of money


April 06, 2017
Adrenaline junkie? Raising capital could be for you!

Adrenaline junkie? Raising capital could be for you!


January 19, 2017
BioWin supports the ‘SMART’ project

BioWin supports the ‘SMART’ project


December 22, 2016
Arthritis Awards Biomarkers biomaterial Biotechnology BioWin Cancer Cancer Therapy cancer treatment cardiology Cell therapy Clinical Studies Clinical Trials CNS Data & Statistics Diabetes Disease DNA Genetics Gosselies heart failure Imaging Immunology in-vitro inflammation Investments & Funding joint disorders Laboratory Nuclear Medicine Obesity oncology osteoarthritis Osteonecrosis Partnering spin-off stem cell UCB UCL UCL spin-off ULB ULg UMons Updates vaccines Wallonia

Recent Posts

  • Imaging beta-cells for better diabetes treatment
  • Walloon radioisotope in the fight against cancer
  • Personalised arthritis medicine saves lots of money
  • Adrenaline junkie? Raising capital could be for you!
  • BioWin supports the ‘SMART’ project

Archives

Win Health
© 2019 Win Health | The health blog of Wallonia. All Rights Reserved.
Powered by Biowin